Group name
Focal treatment (Total)
Groups definition
patients underwent sRARP after focal or whole-gland primary treatment
T2
32 (52)
T3
21 (47)
GS 6
1 (1)
GS 3+4
30 (50)
GS 4+3
20 (33)
GS 8
2 (3)
GS 9
10 (16)